Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
Hess
U
U
Department of Haematology, University of Frankfurt, Germany.
Ganser
A
A
Schnürch
H G
HG
Seipelt
G
G
Ottmann
O G
OG
Falk
S
S
Schulz
G
G
Hoelzer
D
D
D000328:Adult; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D009503:Neutropenia / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000139:chemically induced; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor